Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ADMA Biologics Inc - Common Stock (NQ:ADMA)

19.69 -0.09 (-0.46%)
Streaming Delayed Price Updated: 1:53 PM EST, Dec 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ADMA Biologics Inc - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
ADMA BioCenters Receives FDA Approval for its Eighth Plasma Collection Center, Located in Hammond, LA
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
ADMA Biologics Announces Preliminary Fourth Quarter and Full Year 2022 Revenues and Provides 2023 Financial Guidance
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
Jim Cramer Says Forget AT&T, This 'Class Of The Field' Communications Stock Is Better ↗
On CNBC’s "Mad Money Lightning Round," Jim Cramer said ADMA Biologics, Inc. (NASDAQ: ADMA) is a "great spec, but it is losing money hand over fist. I think it’s very binary. 
Via Benzinga
News headline image
Bulls In A Bear Market: These 10 Stocks Clocked Gains In Excess Of 100% In 2022 ↗
2022 would go down as one of the worst years for the financial markets. The sell-off has been all-pervasive, with stocks, bonds and cryptos all selling off indiscriminately. Even as high-fliers like... 
Via Benzinga
Looking Into ADMA Biologics's Return On Capital Employed ↗
 
Via Benzinga
News headline image
Recap: ADMA Biologics Q2 Earnings ↗
  ADMA Biologics (NASDAQ:ADMA) reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
ADMA Biologics Announces FDA Approval for Room Temperature Storage of ASCENIV™ & BIVIGAM®
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
ADMA Biologics Announces Closing of $69 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
ADMA Biologics Announces Pricing of Public Offering for $60 Million of Common Stock
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
ADMA Biologics Announces Proposed Public Offering of Common Stock
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
ADMA Biologics Announces Preliminary Fourth Quarter 2022 Revenue Estimate
Fourth Quarter 2022 Preliminary Estimated Total Revenues of Approximately $48-$50 Million 
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
Why Cano Health Shares Are Trading Sharply Lower; Here Are 29 Stocks Moving Premarket ↗
Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares jumped 59% to $0.1619 in pre-market trading after dipping 40% on Wednesday. Fast Radius recently filed voluntary petitions for relief under Chapter 11. 
Via Benzinga
News headline image
Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday ↗
Gainers 
Via Benzinga
News headline image
Why Magnite Shares Are Trading Higher By Over 45%? Here Are 69 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares climbed 172% to $0.2769 after dipping 40% on Wednesday. Fast Radius received Bankruptcy court approval of first day motions related to the company's... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Gainers NexImmune (NASDAQ:NEXI) shares rose 38.8% to $0.7 during Thursday's pre-market session. The market value of their outstanding shares is at $16.9 million. 
Via Benzinga
News headline image
Coupang, Rivian Automotive And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
News headline image
ADMA Biologics Announces Third Quarter 2022 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
A Preview Of ADMA Biologics's Earnings ↗
ADMA Biologics (NASDAQ:ADMA) is set to give its latest quarterly earnings report on Wednesday, 2022-11-09. Here's what investors need to know before the announcement. Analysts estimate that ADMA... 
Via Benzinga
News headline image
ADMA Biologics to Report Third Quarter 2022 Financial Results on November 9, 2022
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
ADMA BioCenters Receives FDA Approval for its Seventh Plasma Collection Center, Located in Greensboro, NC
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022 ↗
Upgrades 
Via Benzinga
News headline image
7 A-Rated Stocks to Buy for Less Than $10 ↗
While stocks under $10 don't carry the cache of blue-chip stocks, the returns that they offer can be enticing. 
Via InvestorPlace
News headline image
7 Top-Rated Biotech Stocks to Buy for Q4 ↗
A new White House program makes these seven names some outstanding biotech stocks to buy for the fourth quarter. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
  
Via Benzinga
News headline image
Stocks That Made New Highs On Friday, Aug. 19 ↗
On Friday, in spite of the stock market being down, there were several stocks that actually made new highs. 
Via Talk Markets
News headline image
ADMA Biologics: Earnings Outlook ↗
  ADMA Biologics (NASDAQ:ADMA) is set to give its latest quarterly earnings report on Wednesday, 2022-08-10. Here's what investors need to know before the announcement. Analysts estimate that ADMA... 
Via Benzinga
News headline image
Why ADMA Biologics Shares Are Rising Today ↗
ADMA Biologics Inc (NASDAQ: ADMA) shares are trading higher Monday after the company announced it received U.S. Food and Drug Administration approval for its sixth plasma collection center. 
Via Benzinga
News headline image
Looking Into ADMA Biologics's Return On Capital Employed ↗
Benzinga Pro data, ADMA Biologics (NASDAQ:ADMA) reported Q1 sales of $29.10 million. Earnings fell to a loss of $25.01 million, resulting in a 50.2% decrease from last quarter. 
Via Benzinga
News headline image
Recap: ADMA Biologics Q1 Earnings ↗
ADMA Biologics (NASDAQ:ADMA) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings ADMA Biologics missed estimated... 
Via Benzinga
News headline image
Earnings Outlook For ADMA Biologics ↗
ADMA Biologics (NASDAQ:ADMA) is set to give its latest quarterly earnings report on Wednesday, 2022-05-11. Here's what investors need to know before the announcement. Analysts estimate that ADMA... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.